August 30, 2012
GlaxoSmithKline K.K. (GSK) launched on August 28 its once daily Parkinson’s disease treatment ReQuip CR Tablets 2 mg/8 mg (ropinirole HCl), which were included in the NHI price list on the same day. CR Tablets is a controlled release formulation...read more